4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-063368
Chief Reg & Develop Officer gave up 357 shares (to pay taxes)
- Chief Reg & Develop Officer acquired 1,300 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Powala Christopher Chief Reg & Develop Officer | 2018-12-15 | Option exercise | +1,300 | 138,621 | D | ||
| Powala Christopher Chief Reg & Develop Officer | 2018-12-15 | Shares withheld for taxes | −357 | $7.31 | $2,610 | 138,264 | D |
| Derivatives | |||||||
| Powala Christopher Chief Reg & Develop Officer | 2018-12-15 | Option exercise · Restricted Stock Units | −1,300 | 2,600 | D | ||
Loading xslF345X03/doc4.xml…